생명공학 분야 최고의 파트너, 라온바이오(주)
제품 상세정보
Origin: National Institutes of Health (USA) - 1996 (F169)
Strain name: C3H/HeNRj
Type : Inbred mouse
Colour and related genotype: Agouti mouse
Breeding: Excellent breeder
The C3H strain was developed by STRONG in 1920 from a cross of BAGG ALBINO female with DBA
male. It was selected for a high incidence of mammary tumours. This sensitivity to mammary
tumours is due to an exogenous virus transmitted by the mother’s milk (the Mouse Mammary Tumour
Virus – MMTV). In 1930, STRONG sent a colony to ANDERVONT who in turn sent one to HESTON (at
generation F35). HESTON stock was then transferred to the NIH in 1951 (generation F51). C3H/HeN
mice are used in a wide range of studies. They are homozygous for the Pde6brd1 allele and have an
early onset severe retinal degeneration that causes blindness at weaning age.
This strain has a high incidence of hepatoma. Even if MMTV is not present, virgin and breeding
females can develop mammary tumours. Despite an atherogenic diet, C3H/HeN mice do not develop
aortic atherosclerosis, in contrast to the C57BL/6J. There is a genetically mediated difference
between the C3H/HeN and the C3H/HeJ regarding their response to bacterial endotoxin (LPS). This
response is linked to the TL4 protein (Toll-like receptor 4; previously lps). C3H/HeN are Tlr4lps-n (tolllike receptor 4; normal LPS response), previously LPSn. This strain will have a normal response to an
LPS challenge, it is said to be endotoxin-sensitive. Per contra, the C3H/HeJ strain is Tlr4lps-d,
previously LPSn and said to be endotoxin-resistant.
Important: This strain no longer carries MMTV (Mouse Mammary
Tumour Virus).